Arenicin-1 vs BI 456906

Head-to-head comparison of Arenicin-1 (Arenicin-1) and BI 456906 (BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyArenicin-1BI 456906
CategoryMarine-DerivedWeight Management
Full NameArenicin-1BI 456906, glucagon-like peptide-1/glucagon receptor dual agonist
Molecular Weight2079 DaN/A
Half-Lifen/aApproximately 1 week
Amino Acids21N/A
Typical Dosen/aTrial-dependent; weekly SC dosing
RoutepreclinicalSubcutaneous
Purity≥98%≥98%
Studies Count7610
Research StatusPre-clinicalClinical

Arenicin-1 Benefits

  • antimicrobial
  • anti-biofilm
  • membrane-active

BI 456906 Benefits

  • weight reduction
  • improved glucose control
  • lower liver-fat burden
  • enhanced satiety

Arenicin-1 Dosing

bacterial infection|biofilm disruption

BI 456906 Dosing

once-weekly subcutaneous injection|stepwise titration|ongoing maintenance phase

Arenicin-1 Side Effects

  • Arenicola marina

BI 456906 Side Effects

  • nausea
  • abdominal discomfort
  • diarrhea

Research Overview

Arenicin-1

Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.

BI 456906

Preclinical and early clinical research support meaningful metabolic effects with a tolerable safety profile. It remains investigational and is not commercially available.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Arenicin-1 stacks with:

Arenicola marinabeta-hairpinantibiotic

BI 456906 stacks with:

metforminbupropion
marine-derivedbioactiveantimicrobial peptidebiofilmglp1glucagondual-agonistweight-lossmetabolic-disease